MB Therapeutika Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
220 |
0 |
220 |
2024 |
---|
193,083 |
26,522 |
28,323 |
26,449 |
3,633 |
0.14 |
0.93 |
57.29 |
13.70 |
26,449 |
24,555 |
0 |
51,041 |
Register and
explore Okredo data2024 |
---|
193,083 |
26,522 |
28,323 |
26,449 |
3,633 |
0.14 |
0.93 |
57.29 |
13.70 |
26,449 |
24,555 |
0 |
51,041 |
Register and
explore Okredo data2024
Turnover (€)
193,083 €- *
Sales per employee (€)
26,522 €- *
Profit before tax (€)
28,323 €- *
Net Profit (€)
26,449 €- *
Profit per employee (€)
3,633 €- *
Working capital requirement
0.14 - *
Debt-to-equity ratio
0.93 - *
Total profitability (%)
57.29 %- *
Net profitability (%)
13.70 %- *
Equity (€)
26,449 €- *
Amounts Payable And Liabilities (€)
24,555 €11,061 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
51,041 €23,100 % *